This is a very good report. They can see strong growth coming from sales in the personal wheezometer. This is the asthma device that can give a reading on how severe a persons asthma is. Obvioulsy this device will be used by parents with young children and could be sold all over the globe. KSX is becoming a compelling investment oportunity and is clearly a stand out performer in this sector. Going a lot higher from here.
